Uma Suryadevara, M.D.
Investigator
Dr. Suryadevara had her medical education at Osmania Medical College, her residency at the University of Nevada, School of Medicine and specialized in Oncology and Hematology with her fellowship at the University of New Mexico. She specialized in benign hematology, breast cancer and gynecologic cancer. She values building trusting relationships with her patients and considers it a privilege and solemn responsibility to be part of their advocacy team. She listens and not just hears her patients and open to negotiating goals of care.
Clinical trials
- Clinical trial
Adjuvant Advanced Pancreatic Adenocarcinoma
Randomized Phase III Study of Second-Line Chemotherapy With or Without Panitumumab for KRAS Wild Type, Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status: Open to Enrollment
- Clinical trial
Adjuvant Breast Cancer A012103 OptimiCE-PCR
OptimICE-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy With Checkpoint Inhibitor Therapy
Status: Open to Enrollment
- Clinical trial
Adjuvant Breast NRG-BR009
A Phase III Adjuvant Trial Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 (OFSET)
Status: Open to Enrollment
- Clinical trial
Adjuvant Kidney Cancer STRIKE A032201
Short TeRm Intensified Pembrolizumab (KEytruda) and Tivozanib for High-Risk Renal Cell Carcinoma - STRIKE
Status: Open to Enrollment
- Clinical trial
Adjuvant Non-Small-Cell Lung Cancer C5851005 PADL1NK-005
PADL1NK-005: A Randomized, Phase 3, Open-Label Study to Evaluate PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Status: Open to Enrollment